These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24390523)

  • 1. Corpus callosum atrophy in patients with hereditary diffuse leukoencephalopathy with neuroaxonal spheroids: an MRI-based study.
    Kinoshita M; Kondo Y; Yoshida K; Fukushima K; Hoshi K; Ishizawa K; Araki N; Yazawa I; Washimi Y; Saitoh B; Kira J; Ikeda S
    Intern Med; 2014; 53(1):21-7. PubMed ID: 24390523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative clinical and neuroimaging features of motor-predominant hereditary diffuse leukoencephalopathy with axonal spheroids and primary progressive multiple sclerosis: A preliminary cross-sectional study.
    Saitoh BY; Yamasaki R; Hiwatashi A; Matsushita T; Hayashi S; Mitsunaga Y; Maeda Y; Isobe N; Yoshida K; Ikeda SI; Kira JI
    Mult Scler Relat Disord; 2019 Jun; 31():22-31. PubMed ID: 30901701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MRI comparison between hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS) and primary progressive multiple sclerosis (PPMS)].
    Saitoh BY
    Rinsho Shinkeigaku; 2014; 54(12):1162-4. PubMed ID: 25519970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and neuroimaging characteristics of patients with hereditary diffuse leukoencephalopathy with spheroids (HDLS)].
    Ikeuchi T
    Rinsho Shinkeigaku; 2014; 54(12):1158-61. PubMed ID: 25519969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary diffuse leukoencephalopathy with spheroids - a volumetric and radiological comparison with multiple sclerosis patients and healthy controls.
    Granberg T; Hashim F; Andersen O; Sundal C; Karrenbauer VD
    Eur J Neurol; 2016 Apr; 23(4):817-22. PubMed ID: 26756564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early involvement of the corpus callosum in a patient with hereditary diffuse leukoencephalopathy with spheroids carrying the de novo K793T mutation of CSF1R.
    Kondo Y; Kinoshita M; Fukushima K; Yoshida K; Ikeda S
    Intern Med; 2013; 52(4):503-6. PubMed ID: 23411710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis--a two-year longitudinal MRI/MRSI study of corpus callosum.
    Audoin B; Ibarrola D; Malikova I; Soulier E; Confort-Gouny S; Duong MV; Reuter F; Viout P; Ali-Chérif A; Cozzone PJ; Pelletier J; Ranjeva JP
    Mult Scler; 2007 Jan; 13(1):41-51. PubMed ID: 17294610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI-Defined Corpus Callosal Atrophy in Multiple Sclerosis: A Comparison of Volumetric Measurements, Corpus Callosum Area and Index.
    Granberg T; Bergendal G; Shams S; Aspelin P; Kristoffersen-Wiberg M; Fredrikson S; Martola J
    J Neuroimaging; 2015; 25(6):996-1001. PubMed ID: 25786805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep White Matter Lesions with Persistent Diffusion Restriction on MRI as a Diagnostic Clue: Neuroimaging of a Turkish Family with Hereditary Diffuse Leukoencephalopathy with Spheroids and Literature Review.
    Onder H; Oguz KK; Soylemezoglu F; Varli K
    Ann Indian Acad Neurol; 2020; 23(3):280-288. PubMed ID: 32606513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of the corpus callosum in patients with Alzheimer's disease: Deep learning-based assessment.
    Kamal S; Park I; Kim YJ; Kim YJ; Lee U
    PLoS One; 2021; 16(12):e0259051. PubMed ID: 34941878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter changes contribute to corpus callosum atrophy in the elderly: the LADIS study.
    Ryberg C; Rostrup E; Sjöstrand K; Paulson OB; Barkhof F; Scheltens P; van Straaten EC; Fazekas F; Schmidt R; Erkinjuntti T; Wahlund LO; Basile AM; Pantoni L; Inzitari D; Waldemar G;
    AJNR Am J Neuroradiol; 2008 Sep; 29(8):1498-504. PubMed ID: 18556357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative diffusion tensor imaging study of corpus callosum subregion integrity in bipolar disorder and schizophrenia.
    Li J; Kale Edmiston E; Chen K; Tang Y; Ouyang X; Jiang Y; Fan G; Ren L; Liu J; Zhou Y; Jiang W; Liu Z; Xu K; Wang F
    Psychiatry Res; 2014 Jan; 221(1):58-62. PubMed ID: 24300086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease.
    Teipel SJ; Hampel H; Pietrini P; Alexander GE; Horwitz B; Daley E; Möller HJ; Schapiro MB; Rapoport SI
    Arch Neurol; 1999 Apr; 56(4):467-73. PubMed ID: 10199337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal dominant diffuse leukoencephalopathy with neuroaxonal spheroids.
    van der Knaap MS; Naidu S; Kleinschmidt-Demasters BK; Kamphorst W; Weinstein HC
    Neurology; 2000 Jan; 54(2):463-8. PubMed ID: 10668715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-based morphometric analysis of corpus callosum dimensions of adults in Southeast Nigeria.
    Ajare EC; Campbell FC; Mgbe EK; Efekemo AO; Onuh AC; Nnamani AO; Okwunodulu O; Ohaegbulam SC
    Libyan J Med; 2023 Dec; 18(1):2188649. PubMed ID: 36946121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET.
    Hampel H; Teipel SJ; Alexander GE; Pogarell O; Rapoport SI; Möller HJ
    J Neural Transm (Vienna); 2002 May; 109(5-6):837-55. PubMed ID: 12111472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion tensor group tractography of the corpus callosum in clinically isolated syndrome.
    Lin F; Yu C; Liu Y; Li K; Lei H
    AJNR Am J Neuroradiol; 2011 Jan; 32(1):92-8. PubMed ID: 20966062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When, where, and how the corpus callosum changes in MCI and AD: a multimodal MRI study.
    Di Paola M; Di Iulio F; Cherubini A; Blundo C; Casini AR; Sancesario G; Passafiume D; Caltagirone C; Spalletta G
    Neurology; 2010 Apr; 74(14):1136-42. PubMed ID: 20368633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel CSF-1R mutation in a family with hereditary diffuse leukoencephalopathy with axonal spheroids misdiagnosed as hydrocephalus.
    Wang M; Zhang X
    Neurogenetics; 2019 Aug; 20(3):155-160. PubMed ID: 31093799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AARS2-related ovarioleukodystrophy: Clinical and neuroimaging features of three new cases.
    Taglia I; Di Donato I; Bianchi S; Cerase A; Monti L; Marconi R; Orrico A; Rufa A; Federico A; Dotti MT
    Acta Neurol Scand; 2018 Oct; 138(4):278-283. PubMed ID: 29749055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.